Observations placeholder
Reclast
Identifier
015691
Type of Spiritual Experience
Background
A description of the experience
Zoledronic acid (INN) or zoledronate (marketed by Novartis under the trade names Zometa, Zomera, Aclasta and Reclast) is a bisphosphonate given intravenously. Zometa is “used to prevent skeletal fractures in patients with cancers such as multiple myeloma and prostate cancer, as well as for treating osteoporosis in men and post-menopausal women at increased risk of fracture”.
On Dec, 20, 2016 10,596 people reported to have side effects when taking Reclast.
Among them, 35 people (0.33%) have Hallucination
Time on Reclast when people have Hallucination :
< 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
Hallucination | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Age of people who have Hallucination when taking Reclast :
0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
Hallucination | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 3.45% | 13.79% | 82.76% |
On Dec, 21, 2016 10,596 people reported to have side effects when taking Reclast.
Among them, 1,254 people (11.83%) have Death
Time on Reclast when people have Death :
< 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
Death | 76.92% | 0.00% | 0.00% | 11.54% | 11.54% | 0.00% | 0.00% |
Age of people who have Death when taking Reclast :
0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
Death | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.66% | 6.91% | 91.44% |